Genetic double-agents unmaskedOctober 26, 2004Babraham Institute and Cancer Research UK scientists have discovered that certain enzymes with a key activity in the immune system may be important in stem-cell development, but may also work against us by contributing to the occurrence of cancer. The usual targets A family of enzymes known as DNA deaminases beneficially mutates the genetic code of antibodies to improve their ability to recognise foreign bodies. The usual target for the enzymes' activity is cytosine (C), one of the four building blocks of DNA, however this research has shown that the enzymes can also target another DNA component: methylcytosine (cytosine carrying a methyl chemical group). Double-agents
The discovery may help to explain how methylcytosine is removed from DNA in naturally-occurring situations, such as stem-cell development, but it also suggests a possible mechanism for the mutations that occur in up to one third of hereditary diseases and many cancers. Hence DNA deaminases may be acting as 'double-agents'. Dr Wolf Reik, Head of Developmental Genetics and Imprinting at the Babraham Institute, explains: "The removal of methyl groups from DNA is a sought-after activity implicated in the ability of stem-cells to develop into any other cell in the body, but it is uncertain how this demethylation could occur. The activity we have found in DNA deaminases provides a potential explanation of the mechanism. However, incorrect repair of the DNA during this process may result in mutations that could increase a person's chance of developing cancer." Interpreting the code Methylcytosine is an example of an 'epigenetic' mark - a heritable modification of DNA that affects the way in which a gene is read, without changing the DNA code itself. Epigenetics is an important area of research because epigenetic marks are essential for normal development and they can become misdirected in the cell, leading to cancer and other human diseases. The discovery of the actions of these enzymes, described in a paper published in the Journal of Biological Chemistry, was made by Dr Hugh Morgan and colleagues, working with Dr Wolf Reik at the Babraham Institute, and in collaboration with Dr Svend Peterson-Mahrt at Cancer Research UK. Babraham Institute, The | |||||||||||||||||||||
|
Related Immune System Current Events and Immune System News Articles Children's National researchers develop novel anti-tumor vaccine A novel anti-tumor vaccine for neuroblastoma and melanoma developed by scientists and clinicians at Children's National Medical Center in collaboration with investigators from the University of Iowa is showing significant impact on tumor growth in mice. DNA of good bacteria drives intestinal response to infection A new study shows that the DNA of so-called "good bacteria" that normally live in the intestines may help defend the body against infection. HIV drug maraviroc effective for drug-resistant patients As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death. Hay fever may be best treated with self-adjusted dosing Hay fever, the often seasonal allergy that affects between 10 and 20 percent of the American population, is best controlled through a course of patient-adjusted dosing. Hepatitis B exposure may increase risk for pancreatic cancer In a first-of-its-kind finding, researchers at The University of Texas M. D. Anderson Cancer Center have discovered that exposure to the hepatitis B virus (HBV) may increase the risk of pancreatic cancer. MS patients have higher spinal fluid levels of suspicious immune molecule A protein that helps keep immune cells quiet is more abundant in the spinal fluid of patients with multiple sclerosis (MS), further boosting suspicion that the protein, TREM-2, may be an important contributor to the disease. Study finds association between hepatitis B and pancreatic cancer A new study has shown that evidence of past hepatitis B infection was twice as common in people with pancreatic cancer than in healthy controls. This study is the first to report an association between past exposure to the hepatitis B virus and pancreatic cancer, but researchers cautioned that more studies are necessary to evaluate the nature of the link. LIAI launches new division to look at novel approaches to heart disease and inflammation While cholesterol-lowering drugs and new technologies have significantly advanced the nation's battle against heart disease, it continues to rank as the No. 1 killer of U.S. men and women. But if researchers at the La Jolla Institute for Allergy & Immunology (LIAI) have their way, the body's immune system will become an important player in reducing heart disease. Scientists unmask key HIV protein, open door for more powerful AIDS drugs University of Michigan scientists have provided the most detailed picture yet of a key HIV accessory protein that foils the body's normal immune response. Researchers Investigate Impact of Stress on Police Officers' Physical and Mental Health Policing is dangerous work, and the danger lurks not on the streets alone. More Immune System Current Events and Immune System News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||